This study identifies Estrogen-Related Receptor Gamma (ERRγ) as a clinically relevant oncogene in multiple myeloma (MM), with its elevated expression associated with advanced disease stages and osteolytic bone damage. This evidence concerns the gene ESRRG and Miyoshi myopathy.